We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel Neural Interface to Help Diagnose and Treat Neurological Disorders with Minimal Surgical Risks

By HospiMedica International staff writers
Posted on 19 Nov 2024

Traditional methods of interfacing with the nervous system typically involve creating an opening in the skull to access the brain. More...

Researchers have now introduced an innovative technique called endocisternal interfaces (ECI), which enables electrical recording and stimulation of neural structures, including the brain and spinal cord, through the cerebrospinal fluid (CSF). CSF, which naturally surrounds the nervous system, is used as a conduit for delivering targeted devices. By performing a simple lumbar puncture in the lower back, researchers can insert a flexible catheter to access both the brain and spinal cord. Using miniaturized magnetoelectric-powered bioelectronics, this wireless system can be deployed with a small percutaneous procedure. The flexible catheter electrodes can then be guided from the spinal subarachnoid space to the brain ventricles.

To test the hypothesis, a research team from Rice University (Houston, TX, USA) studied the endocisternal space and measured the width of the subarachnoid, or fluid-filled, space in human patients through magnetic resonance imaging. They further validated the feasibility of this new neural interface by conducting experiments on large animal models, specifically sheep. Their experiments showed that catheter electrodes could be successfully delivered and navigated into the ventricular spaces and brain surface for electrical stimulation. With the magnetoelectric implant, the researchers were able to record electrophysiological signals such as muscle activation and spinal cord potentials.

Preliminary safety findings indicated that the ECI system remained functional with minimal damage up to 30 days after the electronic device was chronically implanted in the brain. Furthermore, the study, published in Nature Biomedical Engineering, revealed that, unlike endovascular neural interfaces that require antithrombotic medication and are constrained by the size and location of blood vessels, ECI provides broader access to neural targets without the need for such medication.

“This is the first reported technique that enables a neural interface to simultaneously access the brain and spinal cord through a simple and minimally invasive lumbar puncture,” said Peter Kan, professor and the Robert L. Moody Sr. Chair of Neurosurgery at UTMB. “It introduces new possibilities for therapies in stroke rehabilitation, epilepsy monitoring and other neurological applications.”


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.